WHO guideline opposes weight-loss drugs, surgery for children under 10

The WHO released a guideline recommending against medication and surgery for obesity in children under ten, while allowing options like Ozempic for adolescents 10-19 after failed lifestyle interventions. This is a policy shift that could influence national treatment protocols and pharmaceutical access, though its direct market impact is limited.